![]() |
|
|
Vol. 287, Issue 3, 1076-1083, December 1998
Department of Pharmacology and Toxicology, School of Pharmacy,
University of Utah, Salt Lake City, Utah
The function of striatopallidal neurons is regulated by
N-methyl-D-aspartate (NMDA) and dopamine D2 receptors.
Previous studies show that immediate early gene induction by D2
receptor blockade is suppressed by NMDA receptor antagonists. Because
the pharmacology of NMDA receptors depends on the incorporation of
different NR2 subunits and NR2 subunits show regional and cellular
differences in their expression in striatum, our study examined whether
different NMDA receptor antagonists would have differential effects on
eticlopride-induced immediate early gene expression in striatum. Male
Sprague-Dawley rats were pretreated with vehicle, CGS 19755, MK-801 or
ifenprodil. Rats then received injections of eticlopride and were
killed 40 min later. In situ hybridization histochemistry
was used to determine the expression of c-fos and
zif268 in the striatum. Eticlopride increased immediate
early gene expression in striatum, with the increase generally being
greater in lateral than in medial striatum. Pretreatment with each of
the NMDA receptor antagonists dose-dependently decreased the expression
of the immediate early genes. This suppression of eticlopride-induced
gene expression was significant only in the medial-central aspect of
striatum. Although there was a trend toward suppression of the gene
induction in lateral striatum, it did not reach statistical
significance and was not typically dose dependent. The data suggest
that different types of NMDA receptor antagonists do not exert
differential effects on D2 dopamine receptor-mediated function in the
striatum. In addition, the data indicate that eticlopride-induced gene
expression in the striatum is not uniformly dependent on NMDA receptor activation.